Meet Humidifeye!
Dry Eye Impacts Millions
-
23 million Americans live with diagnosed Dry Eye Disease (DED)
-
52% receive Rx drops, punctal plugs, and other non-OTC therapies
Treatments Fall Short
-
Rx drops are expensive, have delayed onset, and can sting
-
Conventional plugs can be uncomfortable, unreliable, and frequently fall out
Humidifeye is the world’s easiest dry eye treatment!
A temperature-sensitive gel is delivered to the tear duct using a sterile, disposable autoinjector. With one button press, a plug is delivered which can provide immediate and sustained symptom relief.
✓ Patented ✓ Tested ✓ Ready for Partners
PATIENT BENEFITS
Easy insertion
Complete comfort
Reliable reimbursement
Reduced need for drops
Rapid and sustained improvement
PRACTICE BENEFITS
3-minute treatment
One-size fits all reduces inventory
High reimbursement – CPT68761
Guaranteed patient compliance
Removable for disease management
Instructional Animation
Supported by Optometrists and Ophthalmologists
Product validated in evaluations with 20+ KOLs and in a blinded survey of 178 front-line optometrists and ophthalmologists.
“This would be first in class based on the technology. It’s a stagnant category.” – KOL
Clinical Success
Signs, symptoms, and patient quality of life improvement confirmed in a 44-eye study. Below, average scores for Ocular Surface Disease Index decrease. Humidifeye quickly improved ocular, vision, and environment-related symptoms of Dry Eye.*
Significant Opportunity
Extensive research conducted by Market Scope confirms Humidifeye can make a market.
-
Patients improve quickly, can’t feel the plug, and have reliable reimbursement
-
Clinics save chair time, reduce inventory requirements, and can manage DED with ensured patient compliance
These benefits garner interest from M.D.s and O.D.s far beyond current plug use. Conservative modeling supports $100+ million year 3 revenue.
* Complete data on file at AesculaTech. Contact company representatives for more information.